Safety and Tolerability Study of VVZ-2471 in Healthy Volunteers

Phase 1 Not yet recruiting 60 enrolled Virginia Commonwealth University National Institute on Drug Abuse (NIDA) · collab

RandomizedParallel-groupDouble-blindOther

Summary

The goal of this study is to do follow-up safety testing and how well people are able tolerate an experimental (not FDA approved) medication . This study is seeking non-illicit drug using adults to test the medication. Results of this study will help us to develop future studies to test the medication with people who use substances.

Timeline

Start: 2026-07-15
Primary completion: 2031-12-20
Completion: 2031-12-30

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	VVZ-2471	Unknown	100 mg	—

Indications

No indication recorded.